ARCHIVES

Single-Agent Phase III Trial Comparing Vectibix to Erbitux Meets Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 36 No. 5 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

House Passes Bill On New Cigarette Labels

September 14, 1984

Mammography Screening For Ages 40-49 Not Supported By Data, NIH Pane! Says

January 31, 1997

Funding Opportunities: NKCA Offers Young Researcher Award

March 6, 1998

President Obama Signs FDA User Fee Act Into Law

July 13, 2012

NCCS Networker Volume 3 Issue 1, Winter 1989

January 13, 1989

Q & A With Shannon Brownlee: Task Force Independence at Stake In Debate over PSA Screening

October 6, 2011